Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition
- PMID: 11061607
- DOI: 10.1023/a:1008319114278
Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition
Abstract
Background: Primary health care providers are expected to be directly involved in the genetic testing for cancer susceptibility. This study assessed physicians' knowledge, attitude and perception of their role towards testing for hereditary breast ovarian cancer.
Design: A mail-in survey was sent to all general practitioners, internists, obstetrician-gynecologists and oncologists in private practice in Geneva county, Switzerland. Questions included socio-demographic variables, knowledge about hereditary breast ovarian cancer, attitude towards testing and assessment of their role in the pre- and post-test procedure.
Results: Two hundred fifty-nine (65%) of four hundred questionnaires were returned of which two hundred forty-three (61%) were analysed. Response rates were similar between specialties; women answered more frequently. The majority of the respondents (87%) approved of genetic susceptibility testing. The most common objection to testing was the absence of approved strategies for the prevention and detection of early breast cancer. Most physicians felt they had an active part to play in the pre-test procedure, the disclosure of results, and especially the consultants' long-term care and support (99%). Physicians correctly answered a third (32%) of the knowledge questions. The abstention rate for individual items ranged from 13% to 60%. Scores varied by specialty. Oncologists were more knowledgeable than gynecologists, internists and general practitioners.
Conclusions: The majority of the primary care physicians in this study have a favourable attitude and are ready to play a prominent role in genetic counseling and testing for breast ovarian cancer predisposition. Defective knowledge scores, however, underline the need for targeted educational programs.
Similar articles
-
Swiss primary care physicians' knowledge, attitudes and perception towards genetic testing for hereditary breast cancer.Fam Cancer. 2003;2(3-4):153-8. doi: 10.1023/b:fame.0000004597.29811.8e. Fam Cancer. 2003. PMID: 14707526
-
Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer.Patient Educ Couns. 2003 Feb;49(2):183-8. doi: 10.1016/s0738-3991(02)00117-9. Patient Educ Couns. 2003. PMID: 12566214
-
Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices.Genet Med. 2006 Jun;8(6):361-70. doi: 10.1097/01.gim.0000223544.68475.6c. Genet Med. 2006. PMID: 16778598
-
[Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].Ther Umsch. 2010 Jul;67(7):359-66. doi: 10.1024/0040-5930/a000064. Ther Umsch. 2010. PMID: 20577964 Review. German.
-
Genetic testing for breast and ovarian cancer susceptibility: a family experience.J Midwifery Womens Health. 2004 May-Jun;49(3):210-9. doi: 10.1016/j.jmwh.2004.01.021. J Midwifery Womens Health. 2004. PMID: 15134674 Review.
Cited by
-
Non-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer.Fam Cancer. 2016 Apr;15(2):341-50. doi: 10.1007/s10689-015-9852-6. Fam Cancer. 2016. PMID: 26590592 Free PMC article.
-
Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations.Fam Cancer. 2006;5(4):297-303. doi: 10.1007/s10689-006-7849-x. Epub 2006 Jul 1. Fam Cancer. 2006. PMID: 16819594
-
Assessment of medical knowledge toward genetic testing for individuals with hereditary breast and ovarian cancer syndrome in Brazil.Prev Med Rep. 2023 Aug 2;35:102356. doi: 10.1016/j.pmedr.2023.102356. eCollection 2023 Oct. Prev Med Rep. 2023. PMID: 37649554 Free PMC article.
-
Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer.Fam Cancer. 2015 Jun;14(2):265-72. doi: 10.1007/s10689-014-9770-z. Fam Cancer. 2015. PMID: 25391616
-
Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.BMC Womens Health. 2017 Dec 16;17(1):132. doi: 10.1186/s12905-017-0488-6. BMC Womens Health. 2017. PMID: 29246147 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical